The Regulation of Biologics and Biosimilars: An Introduction

 

Understand differences between biologics and small molecule drugs and effect on regulating generic drugs and biosimilars. Learn regulatory standards for biosimilars and interchangeable biosimilars. Discuss the regulatory exclusivities available for biologics. Address the differences between switching and substitution. Explore the Patent Dance.

Emily Marden, Counsel, Sidley Austin LLP

 

 

This session was recorded as part of FDLI’s Introduction to Drug Law and Regulation Course in April 2022. 

Get Access

$99
  • +$100 for nonmembers

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.

 

On-demand content can be played back on most devices.

 

CLE credit is not currently available for pre-recorded sessions.

Related Content